Alexandria Real Estate Equities, Inc. (NYSE:ARE)
The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Well-run REIT with low leverage, but this quality and more are priced-in. Wtih top-end FFO guidance of $4.57 per share, the stock has an FFO yield of 5.86%. The dividend yield is currently 2.30%. Neither should inspire market beating returns given the current headwinds in commercial real estate.
Recs
Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.
Recs
Cheap for the long haul @ <36.00....Too good to pass on for a 1yr term....Project to make 20-25% in 10-12 months...
Recs
This stock is completely overpriced with P/E 21.37. Terrible long term debt to equity ratio (2.06), tepid return on equity 8.8, and very high payout ratio...This is unsustainable. And, with the federal government in so much debt, I don't expect the national institute of health (NIH) budget to increase anytime soon and NIH money is very important source of income for life sciences industry...
Recs
This is a one-star company within 10% of its 52-week high. It's gotta go down some time!
Recs
I need help
Recs
Market niche for healthcare occupants
Recs
Recs
I believe Aecon Group Inc.'s stock price will grow very much because they are one of the only companies in Canada that can contract to repair the infrastructure in Canada, such as poor road and highway conditions, rebuilding bridges etc. Canada is planning to use ~$33 billion-plus to hire private companies to repair the infrastructure and one of the few companies able to handle the job.
Recs
On a strictly technical basis, my magic charts say this will outperform the S&P
Recs
With a meaty Current Dividend Yield of 3.16% these guys have NOT paid out too much value of the core business. THIS ONE IS GOING TO SHINE LIKE A NEW PENNY!
Recs
Take the dip!
Recs
Recs
ARE is building out BioTech Space in San Francisco's Mission Bay ahead of schedule. Biotech is booming, and San Francisco is where it's happening. ARE is in the right place at the right time.
Recs
great REIT
Recs
Wall Street Pro Pick.
Recs
Following on of my favorite Wallstreet pros with this one.
Recs
BW 2007 Picks
Recs
Location, location, location.
Recs
REIT test . . .
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 20